M. Eichelbaum

Pharmacology · 2000–2006

A researcher in the Science corpus: 6 papers; trusts 4 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

Whom M. Eichelbaum trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. William E. Evans
  2. Magnus Ingelman-Sundberg
  3. Richard M. Weinshilboum
  4. Mary V. Relling

Who trusts M. Eichelbaum overall

  1. Shufeng Zhou
  2. Magnus Ingelman-Sundberg

Papers from M. Eichelbaum's perspective

Ordered by how strongly the researchers M. Eichelbaum trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Inheritance and drug response. (New England Journal of Medicine)
  2. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. (Proceedings of the National Academy of Sciences of the United States of America)
  3. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity (The Pharmacogenomics Journal)
  4. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response (Molecular Psychiatry)
  5. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. (Gastroenterology)
  6. Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism (Clinical Pharmacokinetics)
  7. Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. (Cancer Research)
  8. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. (TIPS - Trends in Pharmacological Sciences)
  9. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. (Journal of Clinical Oncology)
  10. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. (Journal of the American Medical Association (JAMA))

Their papers